Pharmatech Oncology Protocol POI-01-003-050 Gemcitabine NSCLC: A Randomized, Multicenter Study of Combination Therapy Followed by Subsequent Single Agent Gemcitabine Maintenance Therapy or Best Supportive Care in Advanced Non-Small Cell Lung Cancer (NSCLC).
>More...